NASDAQ: CYRX | Industrials / Transportation / USA |
14.52 | -0.2550 | -1.73% | Vol 415.93K | 1Y Perf -16.74% |
Dec 6th, 2023 16:00 DELAYED |
BID | 13.64 | ASK | 15.00 | ||
Open | 14.99 | Previous Close | 14.77 | ||
Pre-Market | - | After-Market | 14.52 | ||
- - | - -% |
Target Price | 33.88 | Analyst Rating | Moderate Buy 2.22 | |
Potential % | 133.41 | Finscreener Ranking | ★★★ 49.96 | |
Insiders Trans % 3/6/12 mo. | -/-100/-100 | Value Ranking | ★★★ 51.11 | |
Insiders Value % 3/6/12 mo. | -/-100/-100 | Growth Ranking | ★★★ 50.02 | |
Insiders Shares Cnt. % 3/6/12 mo. | -/-100/-100 | Income Ranking | — - | |
Price Range Ratio 52W % | 32.42 | Earnings Rating | Sell | |
Market Cap | 710.71M | Earnings Date | 8th Nov 2023 | |
Alpha | 0.01 | Standard Deviation | 0.20 | |
Beta | 1.41 |
Today's Price Range 14.4515.14 | 52W Range 9.0026.01 | 5 Year PE Ratio Range -25.00-11.80 |
Summary:
Buy
Technical Indicators: | Neutral |
Moving Averages: | Strong Buy |
Performance | |||
---|---|---|---|
1 Week | 6.72% | ||
1 Month | 49.49% | ||
3 Months | 8.44% | ||
6 Months | -31.53% | ||
1 Year | -16.74% | ||
3 Years | -69.89% | ||
5 Years | 31.29% | ||
10 Years | 215.60% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | -42.50 | |||
ROE last 12 Months | -54.77 | |||
ROA (5Y Avg) | -7.93 | |||
ROA last 12 Months | -34.18 | |||
ROC (5Y Avg) | -31.78 | |||
ROC last 12 Months | -33.20 | |||
Return on invested Capital Q | -0.65 | |||
Return on invested Capital Y | -35.72 | |||
Assets Turnover | 0.20 | |||
Receivables Turnover | 3.60 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-2.90 | ||||
1.67 | ||||
5.35 | ||||
173.70 | ||||
-32.40 | ||||
-0.06 | ||||
4.51 | ||||
11.01 | ||||
822.17M | ||||
Forward PE | -14.52 | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
14.10 | ||||
15.00 | ||||
0.44 | ||||
0.80 | ||||
-48.60 | ||||
Leverage Ratio | 1.90 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
43.20 | ||||
-121.00 | ||||
-111.60 | ||||
-134.50 | ||||
-15.77 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
176.92M | ||||
3.61 | ||||
106.54 | ||||
85.28 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q03 2023 | -0.31 | -0.31 | 0.00 |
Q02 2023 | -0.25 | -0.42 | -68.00 |
Q01 2023 | -0.18 | -0.16 | 11.11 |
Q04 2022 | -0.21 | -0.24 | -14.29 |
Q03 2022 | -0.13 | -0.15 | -15.38 |
Q02 2022 | -0.15 | -0.17 | -13.33 |
Q01 2022 | -0.20 | -0.31 | -55.00 |
Q04 2021 | -0.15 | -1.32 | -780.00 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
12/2023 QR | -0.31 | -3.33 | Negative |
12/2023 FY | -1.19 | -7.21 | Negative |
3/2024 QR | -0.27 | 10.00 | Positive |
12/2024 FY | -1.02 | 7.27 | Positive |
Next Report Date | - |
Estimated EPS Next Report | -0.31 |
Estimates Count | 6 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 415.93K |
Shares Outstanding | 48.96K |
Shares Float | 43.82M |
Trades Count | 8.22K |
Dollar Volume | 6.12M |
Avg. Volume | 614.33K |
Avg. Weekly Volume | 578.81K |
Avg. Monthly Volume | 631.74K |
Avg. Quarterly Volume | 632.44K |
CryoPort Inc. (NASDAQ: CYRX) stock closed at 14.77 per share at the end of the most recent trading day (a -5.56% change compared to the prior day closing price) with a volume of 638.21K shares and market capitalization of 710.70M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Transportation industry, Industrials sector and employs 600 people. CryoPort Inc. CEO is Jerrell W. Shelton.
The one-year performance of CryoPort Inc. stock is -16.74%, while year-to-date (YTD) performance is -14.87%. CYRX stock has a five-year performance of 31.29%. Its 52-week range is between 9 and 26.01, which gives CYRX stock a 52-week price range ratio of 32.42%
CryoPort Inc. currently has a PE ratio of -2.90, a price-to-book (PB) ratio of 1.67, a price-to-sale (PS) ratio of 5.35, a price to cashflow ratio of 173.70, a PEG ratio of -, a ROA of -34.18%, a ROC of -33.20% and a ROE of -54.77%. The company’s profit margin is -15.77%, its EBITDA margin is -111.60%, and its revenue ttm is $176.92 Million , which makes it $3.61 revenue per share.
Of the last four earnings reports from CryoPort Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.31 for the next earnings report. CryoPort Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for CryoPort Inc. is Moderate Buy (2.22), with a target price of $33.88, which is +133.41% compared to the current price. The earnings rating for CryoPort Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
CryoPort Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
CryoPort Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 14.62, ATR14 : 0.89, CCI20 : 95.85, Chaikin Money Flow : 0.04, MACD : 0.91, Money Flow Index : 48.83, ROC : 10.47, RSI : 62.63, STOCH (14,3) : 64.71, STOCH RSI : 0.19, UO : 52.24, Williams %R : -35.29), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of CryoPort Inc. in the last 12-months were: Baddour Linda (Sold 0 shares of value $0 ), Jerrell W. Shelton (Option Excercise at a value of $1 028 842), Jerrell W. Shelton (Sold 178 229 shares of value $3 643 792 ), Linda Baddour (Option Excercise at a value of $0), Mark W. Sawicki (Option Excercise at a value of $0), Mark W. Sawicki (Sold 2 838 shares of value $58 043 ), Robert Hariri (Sold 1 500 shares of value $20 400 ), Robert S. Stefanovich (Option Excercise at a value of $113 654), Robert S. Stefanovich (Sold 22 146 shares of value $482 568 ), Sawicki Mark (Sold 0 shares of value $-12 790 ), Sawicki Mark (Sold 2 838 shares of value $58 043 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Moderate Buy | Moderate Buy | Moderate Buy |
CryoPort Inc is a provider of temperature-controlled supply chain solutions to the life sciences industry. The company operates via two segments Global Logistics Solutions and Global Bioservices. It's Global Logistics Solutions segment provides temperature-controlled logistics solutions to the life sciences industry through its purpose-built proprietary packaging, information technology and specialized cold chain logistics expertise. While Global Bioservices segment provides a comprehensive temperature-controlled sample management solution to the life science industry, including specimen storage, sample processing, collection, and retrieval. The majority of the revenue is earned from the global logistics solutions segment.
CEO: Jerrell W. Shelton
Telephone: +1 949 470-2300
Address: 112 Westwood Place, Brentwood 37027, TN, US
Number of employees: 600
Thu, 13 Jul 2023 12:20 GMT Analysts Offer Insights on Healthcare Companies: CryoPort (CYRX) and Cara Therapeutics (CARA)
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.